The complex world of post-transcriptional mechanisms: Is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins

Cellular and Molecular Life Sciences

Volumn 69, Issue 4, 2012, Pages 501-517

  Pascale, Alessia ^a   Govoni, Stefano ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimer's disease; Cancer; ELAV like RNA binding proteins; Inflammation; MiRNAs; MRNA stability; Post translational mechanisms

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HU ANTIGEN; MICRORNA; NUCLEIC ACID BINDING PROTEIN; PROTEIN ELAVL1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; CARCINOGENESIS; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; REGULATORY RNA SEQUENCE; REVIEW; RNA STABILITY; TRANSLATION REGULATION;

ALZHEIMER DISEASE; ANIMALS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; INFLAMMATION; MICRORNAS; NEOPLASMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA SPLICING; RNA, MESSENGER;

EID: 84857044531     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0810-7     Document Type: Review

References (183)

1. Moore MJ (2005) From birth to death: the complex lives of eukaryotic mRNAs. Science 309(5740):1514-1518 (Pubitemid 41266467)
2. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351-379
3. Nguyen-Chi M, Morello D (2008) Aberrant regulation of mRNA 30 untranslated region in cancers and inflammation. Med Sci (Paris) 24(3):290-296 (Pubitemid 351427512)
4. Guhaniyogi J, Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265(1-2):11-23 (Pubitemid 32209246)
5. Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59(3):423-450
6. Eberhardt W, Doller A, Akool el S, Pfeilschifter J (2007) Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 114(1):56-73 (Pubitemid 46498160)
7. López de Silanes I, Quesada MP, Esteller M (2007) Aberrant regulation of messenger RNA 30-untranslated region in human cancer. Cell Oncol 29(1):1-17 (Pubitemid 46535188)
8. Chen CY, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20(11):465-470
9. Wilson GM, Brewer G (1999) The search for trans-acting factors controlling messenger RNA decay. Prog Nucleic Acid Res Mol Biol 62:257-291
10. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS, Wilusz J (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21(1-2):165-174 (Pubitemid 34087085)
11. Shaw G, Kamen R (1986) A conserved AU sequence from the 30 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46(5):659-667
12. Bakheet T, Williams BR, Khabar KS (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34(Database issue):D111-D114
13. Barreau C, Paillard L, Osborne HB (2006) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33(22):7138-7150
14. Zhang T, Kruys V, Huez G, Gueydan C (2002) AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors. Biochem Soc Trans 30(Pt 6):952-958 (Pubitemid 36002387)
15. Good PJ (1995) A conserved family of ELAV-like genes in vertebrates. Proc Natl Acad Sci USA 92(10):4557-4561
16. Brennan CM, Steitz JA (2001) HuR and mRNA stability. Cell Mol Life Sci 58(2):266-277 (Pubitemid 32217358)
17. Bolognani F, Perrone-Bizzozero NI (2008) RNA-protein interactions and control of mRNA stability in neurons. J Neurosci Res 86(3):481-489 (Pubitemid 351204460)
18. Pascale A, Amadio M, Quattrone A (2008) Defining a neuron: neuronal ELAV proteins. Cell Mol Life Sci 65(1):128-140 (Pubitemid 351152226)
19. Keene JD (1999) Why is Hu where? Shuttling of early responsegene messenger RNA subsets. Proc Natl Acad Sci USA 96:5-7 (Pubitemid 29036041)
20. Hinman MN, Lou H (2008) Diverse molecular functions of Hu proteins. Cell Mol Life Sci 65(20):3168-3181
21. Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD (1997) Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol 17(2):954-962 (Pubitemid 27044394)
22. Antic D, Lu N, Keene JD (1999) ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev 13(4):449-461 (Pubitemid 29108760)
23. Kullmann M, Göpfert U, Siewe B, Hengst L (2002) ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 50UTR. Genes Dev 16(23):3087-3099 (Pubitemid 35424195)
24. Bolognani F, Contente-Cuomo T, Perrone-Bizzozero NI (2010) Novel recognition motifs and biological functions of the RNAbinding protein HuD revealed by genome-wide identification of its targets. Nucleic Acids Res 38(1):117-130
25. Vlasova IA, Tahoe NM, Fan D, Larsson O, Rattenbacher B, Sternjohn JR, Vasdewani J, Karypis G, Reilly CS, Bitterman PB, Bohjanen PR (2008) Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29(2):263-270 (Pubitemid 351172819)
26. Wein G, Rössler M, Klug R, Herget T (2003) The 30-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR. Eur J Biochem 270(2):350-365 (Pubitemid 36114933)
27. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM (1991) HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to ELAV and Sex-lethal. Cell 67(2):325-333 (Pubitemid 121001448)
28. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB (1992) The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 141(4):881-886
29. Posner JB (1994) The anti-Hu syndrome: a model paraneoplastic disorder. Recent Results Cancer Res 135:77-90
30. Robinow S, Campos AR, Yao KM, White K (1988) The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science 242(4885):1570-1572
31. Samson ML (2008) Rapid functional diversification in the structurally conserved ELAV family of neuronal RNA-binding proteins. BMC Genomics 9:392-402
32. Koushika SP, Lisbin MJ, White K (1996) ELAV, a Drosophila neuron-specific protein, mediates the generation of an alternatively spliced neural protein isoform. Curr Biol 6(12):1634-1641 (Pubitemid 27050231)
33. Koushika SP, Soller M, White K (2000) The neuron-enriched splicing pattern of Drosophila erect wing is dependent on the presence of ELAV protein. Mol Cell Biol 20(5):1836-1845 (Pubitemid 30100200)
34. Jiménez F, Campos-Ortega JA (1987) Genes in subdivision 1B of the Drosophila melanogaster X chromosome and their influence on neural development. J Neurogenet 4(4):179-200
35. Nagai K, Oubridge C, Ito N, Avis J, Evans P (1995) The RNP domain: a sequence-specific RNA-binding domain involved in processing and transport of RNA. Trends Biochem Sci 20(6):235-240
36. Deschenes-Furry J, Angus LM, Bélanger G, Mwanjewe J, Jasmin BJ (2005) Role of ELAV-like RNA-binding proteins HuD and HuR in the post-transcriptional regulation of acetylcholinesterase in neurons and skeletal muscle cells. Chem Biol Interact 157-158:43-49 (Pubitemid 41757632)
37. Fan XC, Steitz JA (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 95(26):15293-15298 (Pubitemid 29018692)
38. Wang X, Tanaka Hall TM (2001) Structural basis for recognition of AU-rich element RNA by the HuD protein. Nat Struct Biol 8(2):141-145 (Pubitemid 32116066)
39. Ma WJ, Chung S, Furneaux H (1997) The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res 25:3564-3569 (Pubitemid 27390172)
40. Beckel-Mitchener AC, Miera A, Keller R, Perrone-Bizzozero NI (2002) Poly(A) tail length-dependent stabilization of GAP-43 mRNA by the RNA-binding protein HuD. J Biol Chem 277:27996-28002 (Pubitemid 34966749)
41. Gao FB, Keene JD (1996) Hel-N1/Hel-N2 proteins are bound to poly(A) ? mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci 109(Pt 3):579-589 (Pubitemid 26092680)
42. Kasashima K, Sakashita E, Saito K, Sakamoto H (2002) Complex formation of the neuron-specific ELAV-like Hu RNAbinding proteins. Nucleic Acids Res 30:4519-4526 (Pubitemid 35277262)
43. Fialcowitz-White EJ, Brewer BY, Ballin JD, Willis CD, Toth EA, Wilson GM (2007) Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNAdestabilizing sequences. J Biol Chem 282:20948-20959 (Pubitemid 47099908)
44. Toba G, White K (2008) The third RNA recognition motif of Drosophila ELAV protein has a role in multimerization. Nucleic Acids Res 36(4):1390-1399 (Pubitemid 351330953)
45. Gallouzi IE, Steitz JA (2001) Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294(5548):1895-1901 (Pubitemid 33101580)
46. Erratum in: Science 296(5565):47, 2002
47. Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNAbinding proteins and the messages they carry. Nat Rev Mol Cell Biol 3(3):195-205
48. Doller A, Pfeilschifter J, Eberhardt W (2008) Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNAbinding protein HuR. Cell Signal 20(12):2165-2173
49. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Müller M, Gaestel M, Resch K, Holtmann H (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AUrich region-targeted mechanism. EMBO J 18(18):4969-4980 (Pubitemid 29443799)
50. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C (2001) Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogenactivated protein kinase. Mol Cell Biol 21(17):5778-5789 (Pubitemid 32737795)
51. Wang W, Fan J, Yang X, Fürer-Galban S, Lopez de Silanes I, von Kobbe C, Guo J, Georas SN, Foufelle F, Hardie DG, Carling D, Gorospe M (2002) AMP-activated kinase regulates cytoplasmic HuR. Mol Cell Biol 22(10):3425-3436 (Pubitemid 34453982)
52. Pascale A, Amadio M, Scapagnini G, Lanni C, Racchi M, Provenzani A, Govoni S, Alkon DL, Quattrone A (2005) Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc Natl Acad Sci USA 102(34): 12065-12070 (Pubitemid 41291129)
53. Doller A, Schlepckow K, Schwalbe H, Pfeilschifter J, Eberhardt W (2010) Tandem phosphorylation of serines 221 and 318 by protein kinase Cdelta coordinates mRNA binding and nucleocytoplasmic shuttling of HuR. Mol Cell Biol 30(6):1397-1410
54. Antic D, Keene JD (1998) Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus. J Cell Sci 111(Pt 2): 183-197 (Pubitemid 28064144)
55. Keene JD (2010) Minireview: global regulation and dynamics of ribonucleic Acid. Endocrinology 151(4):1391-1397
56. Keene JD, Tenenbaum SA (2002) Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9(6):1161-1167 (Pubitemid 34722296)
57. Modrek B, Lee C (2002) A genomic view of alternative splicing. Nat Genet 30:13-19
58. Xu Q, Modrek B, Lee C (2002) Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 30(17):3754-3766 (Pubitemid 35012448)
59. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40(12):1413-1415
60. Erratum in: (2009) Nat Genet 41(6):762
61. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221):470-476 (Pubitemid 352759009)
62. Lisbin MJ, Qiu J, White K (2001) The neuron-specific RNAbinding protein ELAV regulates neuroglian alternative splicing in neurons and binds directly to its pre-mRNA. Genes Dev 15(19):2546-2561 (Pubitemid 32937865)
63. Soller M, White K (2003) ELAV inhibits 30-end processing to promote neural splicing of ewg pre-mRNA. Genes Dev 17(20): 2526-2538 (Pubitemid 37271423)
64. Soller M, White K (2005) ELAV multimerizes on conserved AU4-6 motifs important for ewg splicing regulation. Mol Cell Biol 25(17):7580-7591 (Pubitemid 41170120)
65. Zhu H, Hasman RA, Barron VA, Luo G, Lou H (2006) A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. Mol Biol Cell 17(12):5105-5114 (Pubitemid 44907354)
66. Zhu H, Hasman RA, Young KM, Kedersha NL, Lou H (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP premRNA. Mol Cell Biol 23(17):5959-5971 (Pubitemid 37013077)
67. Bellavia D, Mecarozzi M, Campese AF, Grazioli P, Talora C, Frati L, Gulino A, Screpanti I (2007) Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing. EMBO J 26(6):1670-1680 (Pubitemid 46480945)
68. Izquierdo JM (2010) Cell-specific regulation of Fas exon 6 splicing mediated by Hu antigen R. Biochem Biophys Res Commun 402(2):324-328
69. Okano HJ, Darnell RB (1997) A hierarchy of Hu RNA-binding proteins in developing and adult neurons. J Neurosci 17(9): 3024-3037 (Pubitemid 27175816)
70. Antic D, Keene JD (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 61(2): 273-278 (Pubitemid 27382301)
71. Wang H, Molfenter J, Zhu H, Lou H (2010) Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members. Nucleic Acids Res 38(11):3760-3770
72. Kasashima K, Terashima K, Yamamoto K, Sakashita E, Sakamoto H (1999) Cytoplasmic localization is required for the mammalian ELAV-like protein HuD to induce neuronal differentiation. Genes Cells 4(11):667-683 (Pubitemid 30043547)
73. Ratti A, Fallini C, Colombrita C, Pascale A, Laforenza U, Quattrone A, Silani V (2008) Post-transcriptional regulation of neuro-oncological ventral antigen 1 by the neuronal RNAbinding proteins ELAV. J Biol Chem 283(12):7531-7541
74. Ule J, Ule A, Spencer J, Williams A, Hu JS, Cline M, Wang H, Clark T, Fraser C, Ruggiu M, Zeeberg BR, Kane D, Weinstein JN, Blume J, Darnell RB (2005) Nova regulates brain-specific splicing to shape the synapse. Nat Genet 37(8):844-852 (Pubitemid 41077110)
75. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, Okano HJ, Yang YY, Darnell RB (2000) Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25(2):359-371
76. Lutz CS (2008) Alternative polyadenylation: a twist on mRNA 30 end formation. ACS Chem Biol 3(10):609-617
77. Zhu H, Zhou HL, Hasman RA, Lou H (2007) Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences. J Biol Chem 282(4):2203-2210 (Pubitemid 47076748)
78. Tian B, Hu J, Zhang H, Lutz CS (2005) A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 33(1):201-212 (Pubitemid 40276942)
79. Khabar KS (2005) The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res 25(1):1-10 (Pubitemid 40105586)
80. Slevin MK, Gourronc F, Hartley RS (2007) ElrA binding to the 30UTR of cyclin E1 mRNA requires polyadenylation elements. Nucleic Acids Res 35(7):2167-2176 (Pubitemid 47073705)
81. Al-Ahmadi W, Al-Ghamdi M, Al-Haj L, Al-Saif M, Khabar KS (2009) Alternative polyadenylation variants of the RNA-binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res 37(11):3612-3624
82. Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A (2003) Posttranscriptional regulation of gene expression by degradation of messenger RNAs. J Cell Physiol 195(3):356-372 (Pubitemid 36529864)
83. Laroia G, Cuesta R, Brewer G, Schneider RJ (1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284(5413):499-502 (Pubitemid 29289625)
84. Loflin P, Chen CY, Shyu AB (1999) Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 13(14):1884-1897 (Pubitemid 29353054)
85. Gao FB, Carson CC, Levine T, Keene JD (1994) Selection of a subset of mRNAs from combinatorial 30 untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci USA 91(23):11207-11211
86. Bhattacharya S, Giordano T, Brewer G, Malter JS (1999) Identification of AUF-1 ligands reveals vast diversity of early response gene mRNAs. Nucleic Acids Res 27(6):1464-1472 (Pubitemid 29206287)
87. Chen CY, Xu N, Shyu AB (2002) Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol Cell Biol 22(20):7268-7278
88. Lu JY, Schneider RJ (2004) Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J Biol Chem 279(13):12974-12979 (Pubitemid 38445873)
89. Blaxall BC, Pende A, Wu SC, Port JD (2002) Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNP D) and HuR for A ? U-rich mRNAs. Mol Cell Biochem 232(1-2):1-11 (Pubitemid 34413875)
90. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M (2004) Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23(15): 3092-3102 (Pubitemid 39093603)
91. Krützfeldt J, Stoffel M (2006) MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 4(1):9-12 (Pubitemid 43942256)
92. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233
93. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114
94. Kedde M, Agami R (2008) Interplay between microRNAs and RNA-binding proteins determines developmental processes. Cell Cycle 7(7):899-903 (Pubitemid 351573784)
95. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F (2010) microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 125(1):92-104
96. Eulalio A, Huntzinger E, Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132:9-14
97. Chekulaeva M, Filipowicz W (2009) Mechanisms of miRNAmediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21:452-460
98. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18:504-511 (Pubitemid 38372808)
99. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105 (Pubitemid 46991392)
100. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA, Pasquinelli AE, Shiekhattar R (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447(7146): 823-828 (Pubitemid 46920131)
101. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z (2007) An mRNA m7G cap bindinglike motif within human Ago2 represses translation. Cell 129(6):1141-1151 (Pubitemid 46891041)
102. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Jünemann C, Niepmann M (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27:3300-3310
103. Orom UA, Nielsen FC, Lund AH (2008) MicroRNA-10a binds the 5-UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30:460-471 (Pubitemid 351672378)
104. Vasudevan S, Tong Y, Steitz JA (2008) Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 7:1545-1549 (Pubitemid 351881318)
105. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J (2005) Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120(5):623-634 (Pubitemid 40343075)
106. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125(6):1111-1124 (Pubitemid 43866197)
107. Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, le Sage C, Nagel R, Voorhoeve PM, van Duijse J, Ørom UA, Lund AH, Perrakis A, Raz E, Agami R (2007) RNAbinding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131(7):1273-1286
108. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M (2009) HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 23(15):1743-1748
109. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M (2008) miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci USA 105(51):20297-20302
110. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, Cabo R, Gorospe M (2010) miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9(7):1354-1359
111. Abdelmohsen K, Hutchison ER, Lee EK, Kuwano Y, Kim MM, Masuda K, Srikantan S, Subaran SS, Marasa BS, Mattson MP, Gorospe M (2010) miR-375 inhibits differentiation of neurites by lowering HuD levels. Mol Cell Biol 30(17):4197-4210
112. Quattrone A, Pascale A, Nogues X, Zhao W, Gusev P, Pacini A, Alkon DL (2001) Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins. Proc Natl Acad Sci USA 98(20):11668-11673 (Pubitemid 32928786)
113. Pascale A, Gusev PA, Amadio M, Dottorini T, Govoni S, Alkon DL, QuattroneA (2004) Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci USA 101(5):1217-1222 (Pubitemid 38182669)
114. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362(4):329-344
115. Racchi M, Govoni S (2003) The pharmacology of amyloid precursor protein processing. Exp Gerontol 38(1-2):145-157 (Pubitemid 36110508)
116. Racchi M, Mazzucchelli M, Pascale A, Sironi M, Govoni S (2003) Role of protein kinase C alpha in the regulated secretion of the amyloid precursor protein. Mol Psychiatry 8(2):209-216 (Pubitemid 36315229)
117. Mileusnic R, Lancashire CL, Johnston AN, Rose SP (2000) APP is required during an early phase of memory formation. Eur J Neurosci 12(12):4487-4495 (Pubitemid 32037856)
118. Marcello E, Epis R, Di Luca M (2008) Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis. Eur J Pharmacol 585(1):109-118
119. Chen QS, Kagan BL, Hirakura Y, Xie CW (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid betapeptides. J Neurosci Res 60(1):65-72 (Pubitemid 30176750)
120. Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M (2002) [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8(2):67-74 (Pubitemid 35013574)
121. Tyler SJ, Dawbarn D, Wilcock GK, Allen SJ (2002) alpha-and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun 299(3):373-376 (Pubitemid 35365637)
122. Amadio M, Pascale A, Wang J, Ho L, Quattrone A, Gandy S, Haroutunian V, Racchi M, Pasinetti GM (2009) nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing. J Alzheimer's Dis 16(2):409-419
123. Rossi D, Amadio M, Carnevale Baraglia A, Azzolina O, Ratti A, Govoni S, Pascale A, Collina S (2009) Discovery of small peptides derived from embryonic lethal abnormal vision proteins structure showing RNA-stabilizing properties. J Med Chem 52(16):5017-5019
124. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor betasecretase in Alzheimer's disease. Ann Neurol 51(6):783-786 (Pubitemid 34568861)
125. Marambaud P, Chevallier N, Ancolio K, Checler F (1998) Posttranscriptional contribution of a cAMP-dependent pathway to the formation of alpha-and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP. Mol Med 4(11): 715-723 (Pubitemid 29051377)
126. Rossner S, Sastre M, Bourne K, Lichtenthaler SF (2006) Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer's disease. Prog Neurobiol 79(2): 95-111 (Pubitemid 44247281)
127. Boissonneault V, Plante I, Rivest S, Provost P (2009) MicroRNA-298 and microRNA-328 regulate expression of mouse betaamyloid precursor protein-converting enzyme 1. J Biol Chem 284(4):1971-1981
128. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28(5):1213-1223 (Pubitemid 351186356)
129. Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL (2011) Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet 88(2):232-238
130. Yamada K, Iwayama Y, Hattori E, Iwamoto K, Toyota T, Ohnishi T, Ohba H, Maekawa M, Kato T, Yoshikawa T (2011) Genome-wide association study of schizophrenia in Japanese population. PLoS One 6(6):e20468
131. Noureddine MA, Qin XJ, Oliveira SA, Skelly TJ, van der Walt J, Hauser MA, Pericak-Vance MA, Vance JM, Li YJ (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 117(1):27-33 (Pubitemid 40778779)
132. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172(1-2):151-154 (Pubitemid 24178765)
133. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70 (Pubitemid 30046295)
134. Audic Y, Hartley RS (2004) Post-transcriptional regulation in cancer. Biol Cell 96(7):479-498
135. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer-a quantitative western blot analysis. Ann Neurol 27(5):544-552 (Pubitemid 20149976)
136. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD (2000) Differential expression and localization of the mRNA-binding proteins, AU-rich element mRNA-binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28(2):76-83 (Pubitemid 30432475)
137. López de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES, Gorospe M (2003) Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22(46):7146-7154 (Pubitemid 37378547)
138. Denkert C, Weichert W, Winzer KJ, Müller BM, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S (2004) Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 10(16): 5580-5586 (Pubitemid 39100499)
139. Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux H, Hla T, Haglund C, Ristimäki A (2005) Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65(6):2157-2161 (Pubitemid 40490122)
140. Brewer G, Saccani S, Sarkar S, Lewis A, Pestka S (2003) Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A ? U-rich element-binding factor AUF1. J Interferon Cytokine Res 23(10):553-564 (Pubitemid 37323677)
141. Amadio M, Scapagnini G, Laforenza U, Intrieri M, Romeo L, Govoni S, Pascale A (2008) Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Curr Pharm Des 14:2651-2658
142. Amadio M, Bucolo C, Leggio GM, Drago F, Govoni S, Pascale A (2010) The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol 80(8):1230-1237
143. Vázquez-Chantada M, Fernández-Ramos D, Embade N, Martí-nez-Lopez N, Varela-Rey M, Woodhoo A, Luka Z, Wagner C, Anglim PP, Finnell RH, Caballería J, Laird-Offringa IA, Gorospe M, Lu SC, Mato JM, Martínez-Chantar ML (2010) HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology 138(5):1943-1953
144. Mazan-Mamczarz K, Hagner PR, Corl S, Srikantan S, Wood WH, Becker KG, Gorospe M, Keene JD, Levenson AS, Gartenhaus RB (2008) Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene 27(47):6151-6163
145. D'Alessandro V, Muscarella LA, la Torre A, Bisceglia M, Parrella P, Scaramuzzi G, Storlazzi CT, Trombetta D, Kok K, De Cata A, Sperandeo M, Zelante L, Carella M, Vendemiale G (2010) Molecular analysis of the gene in neuroendocrine lung cancers. Lung Cancer 67(1):69-75
146. Lebwohl D.E., Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N (1994) A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9(7):1925-1929 (Pubitemid 24194159)
147. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa Lucia B, Duret L, Vuillaume M, Coiffier B, Bryon P-A, Magaud JP (1994) Rearrangement of CCND1 (BCL1/PRAD1) 30 untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood 83(12): 3689-3696
148. Hollis GF, Gazdar AF, Bertness V, Kirsch IR (1988) Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Mol Cell Biol 8(1):124-129 (Pubitemid 18015573)
149. Aghib DF, Bishop JM, Ottolenghi S, Guerrasio A, Serra A, Saglio G (1990) A 30 truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. Oncogene 5(5):707-711
150. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857-866 (Pubitemid 44629897)
151. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043): 834-838 (Pubitemid 40839735)
152. Xu F, Zhang X, Lei Y, Liu X, Liu Z, Tong T, Wang W (2010) Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J Cell Biochem 111(3):727-734
153. Guo X, Wu Y, Hartley RS (2009) MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol 6(5):575-583
154. Fan J, Heller NM, Gorospe M, Atasoy U, Stellato C (2005) The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur Respir J 26(5):933-947 (Pubitemid 41632053)
155. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10(3):387-398 (Pubitemid 29165293)
156. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4(5):445-454 (Pubitemid 26354654)
157. Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P (2000) TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 19(15):4154-4163 (Pubitemid 30608553)
158. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J (2001) The 30 untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21(3):721-730 (Pubitemid 32104721)
159. Krishnamurthy P, Lambers E, Verma S, Thorne T, Qin G, Losordo DW, Kishore R (2010) Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J 24(7):2484-2494
160. Chae MJ, Sung HY, Kim EH, Lee M, Kwak H, Chae CH, Kim S, Park WY (2009) Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA. Exp Mol Med 41(11):824-831
161. Di Marco S, Hel Z, Lachance C, Furneaux H, Radzioch D (2001) Polymorphism in the 30-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res 29(4): 863-871 (Pubitemid 32162253)
162. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190 (Pubitemid 23115005)
163. Kishore R, Tebo JM, Kolosov M, Hamilton TA (1999) Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J Immunol 162(5):2457-2461 (Pubitemid 29309260)
164. Rennick D, Davidson N, Berg D (1995) Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol 76(3 Pt 2):S174-S178
165. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, Qin G, Goukassian D, Zhu Y, Losordo DW, Kishore R (2006) IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 20(12):2112-2114
166. Winzen R, Gowrishankar G, Bollig F, Redich N, Resch K, Holtmann H (2004) Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24(11):4835-4847 (Pubitemid 38668049)
167. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 104(2):e9-e18
168. Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ (2006) The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol 26(12):2622-2629
169. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280-288 (Pubitemid 38610351)
170. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270(16): 9558-9563
171. Rhee WJ, Ni CW, Zheng Z, Chang K, Jo H, Bao G (2010) HuR regulates the expression of stress-sensitive genes and mediates inflammatory response in human umbilical vein endothelial cells. Proc Natl Acad Sci USA 107(15):6858-6863
172. Katsanou V, Papadaki O, Milatos S, Blackshear PJ, Anderson P, Kollias G, Kontoyiannis DL (2005) HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 19(6):777-789 (Pubitemid 41316672)
173. Stamou P, Kontoyiannis DL (2010) Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. Curr Dir Autoimmun 11:61-79
174. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316(5824):608-611 (Pubitemid 46683148)
175. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27(6):847-859 (Pubitemid 350258623)
176. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007) Regulation of the germinal center response by microRNA-Science 316(5824):604-608 (Pubitemid 46683147)
177. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179(8):5082-5089
178. Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175-205
179. Chang TC, Mendell JT (2007) microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8:215-239
180. Yang M, Mattes J (2008) Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 117(1):94-104 (Pubitemid 350199690)
181. Kwak PB, Iwasaki S, Tomari Y (2010) The microRNA pathway and cancer. Cancer Sci 101(11):2309-2315
182. Law PT, Wong N (2011) Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 26(3):437-449
183. Zhou S, Yu B, Qian T, Yao D, Wang Y, Ding F, Gu X (2011) Early changes of microRNAs expression in the dorsal root ganglia following rat sciatic nerve transection. Neurosci Lett. doi 10.1016/j.neulet.2011.02.064